Abtract
A case of a patient with an uncommon thyroid carcinoma, showing histological and immunohistochemical features of both follicular and parafollicular cells is described. Somatic point mutation (ATG to ACG heterozygotic mutation at codon 918) of the RET proto-oncogene was detected in tumor tissue, as confirmed by immunohistochemical expression of RET oncoprotein. Our findings suggest that constitutive RET proto-oncogene activation may be involved in the development of mixed medullary-follicular thyroid carcinoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rosai J., Carcangiu M.L., De Lellis R.A. Tumors of the thyroid gland. In: Atlas of tumor pathology. Armed Force Institute of Pathology, Washington, 1992.
Giuffrida D., Gharib H. Current diagnosis and management of medullary thyroid carcinoma. Ann. Oncol. 1998, 9: 695–701.
Wohllk N., Cote G.J., Bugalho M.M.J., Ordonez N., Evans D.B., Goepfert H., Khorana S., Shultz P., Richards S., Gagel R.F. Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 1996, 81: 3740–3745.
Santoro M., Carlomagno F., Melillo R.M., Billaud M., Vecchio G., Fusco A. Molecular mechanisms of RET activation in human neoplasia. J. Endocrinol. Invest. 1999, 22: 811–819.
Eng C., Clayton D., Schuffenecker I., Lenoir G., Gilbert D.V.M., Cote G., Gagel R., Ploos van Amstel H.K., Lips C.J., Nishisho I., Takai S.I., Marsh D.J., Robinson B.G., Frank-Raue K., Raue F., Xue F., Noll W.W., Romei C., Pacini F., Fink M., Niederle B., Zedenius J., Nordenskjold M., Komminoth P., Hendy G.N., Gharib H., Thibodeau S., Lacroix A., Frilling A., Ponder B.A.J., Mulligan L.M. The relationship between specific RET Proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: international RET mutation consortium analysis. JAMA 1996, 276: 1575–1579.
Papotti M., Negro F., Carney J.A., Bussolati G., Lloyd R.V. Mixed medullary-follicular carcinoma of the thyroid. A morphological, immunohistochemical and in situ hybridization analysis of 11 cases. Virchows Arch. 1997, 430: 397–405.
Hales M., Rosenau W., Okerlund M.D, Galante M. Carcinoma of the thyroid with a medullary and follicular pattern: morphologic, immunohistochemical, and clinical laboratory studies. Cancer 1982, 50: 1352–1359.
Sobrinho-Simoes M. Mixed medullary and follicular carcinoma of the thyroid. Histopathology 1993, 23: 287–289.
Hedinger C., Williams E.D., Sobin L.H. Histological typing of thyroid tumours. In: World Health Organization (Ed.), International histological classification of tumours. Springer-Verlag, Berlin, 1988, p. 1.
Williams E.D., Toyu C.E., Harach H.R. The ultimobranchial gland and congenital thyroid abnormalities in man. J. Pathol. 1989, 159: 135–141.
Triggs S.M., Williams E.D. Experimental carcinogenesis in the thyroid follicular and C cells. A comparison of the effect of variation in dietary calcium and of radiation. Acta Endocrinol. (Copenh.) 1977, 85: 84–92.
Lax S.F., Beham A., Kronberger-Schonecker D., Langsteger W., Denk H. Coexistence of papillary and medullary carcinoma of the thyroid gland-mixed or collision tumour? Clinicopathological analysis of three cases. Virchows Arch. 1994, 42: 441–447.
Pastolero G.C., Coire C.I., Asa S.L. Concurrent medullary and papillary carcinomas of thyroid with lymph node metastases. A collision phenomenon. Am. J. Surg. Pathol. 1996, 20: 245–250.
Takahashi M., Buma Y., Iwamoto T., Inaguma Y., Ikeda H., Hiai H. Cloning and expression of the RET proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 1988, 3: 571–578.
Chiefari E., Russo D., Giuffrida D., Zampa G.A., Meringolo D., Arturi F., Chiodini I., Bianchi D., Attard M., Trischitta V., Bruno R., Giannasio P., Pontecorvi A., Filetti S. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma. J. Endocrinol. Invest. 1998, 21: 358–364.
Volante M., Papotti M., Roth J., Saremaslani P., Speel E.J.M., Lloyd R.V., Carney J.A., Heits P.U., Bussolati G., Komminoth P. Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components. Am. J. Pathol. 1999, 155: 1499–1509.
Komminoth P., Kunz E.K., Matias-Guiu X., Hiort O., Christiansen G., Colomer A., Roth J., Heitz P.U. Analysis of RET proto-oncogene point mutations distinguishes heritable from nonheritable medullary carcinomas. Cancer 1995, 76: 479–489.
Romei C., Elisei R., Pinchera A., Ceccherini I., Molinaro E., Mancusi F., Martino E., Romeo G., Pacini F. Somatic mutations of the RET proto-oncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J. Clin. Endocrinol. Metab. 1996, 81: 1619–1622.
Holm R., Sobrinho-Simoes M., Nesland J.M., Johannessen J.V. Concurrent production of calcitonin and thyroglobulin by the same neoplastic cells. Ultrastruct. Pathol. 1986, 10: 241–248.
Noel M., Delehaye M.C., Segond N, Lasmoles F., Caillon B, Gardet P, Fragn P., Moukhtar M.S. Study of calcitonin and thyroglobulin gene expression in human mixed follicular and medullary thyroid carcinoma. Thyroid 1991, 1: 249–256.
Uribe M., Fenoglio-Preiser C., Grimes M., Feind C. Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature. Am. J. Surg. Pathol. 1985, 9: 577–594.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Orlandi, F., Chiefari, E., Caraci, P. et al. RET proto-oncogene mutation in a mixed medullaryfollicular thyroid carcinoma. J Endocrinol Invest 24, 51–55 (2001). https://doi.org/10.1007/BF03343809
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343809